Endologix Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
16,068.00
32,418.00
50,424.00
154,677.00
66,400.00
Depreciation, Depletion & Amortization
2,351.00
3,283.00
5,886.00
9,149.00
9,111.00
Other Funds
7,418.00
-
481.00
133.00
-
Funds from Operations
2,126.00
19,299.00
40,256.00
79,308.00
35,992.00
Changes in Working Capital
632.00
7,035.00
9,164.00
6,501.00
1,926.00
Net Operating Cash Flow
1,494.00
26,334.00
31,092.00
72,807.00
37,918.00
Capital Expenditures
2,862.00
13,461.00
4,191.00
2,796.00
1,170.00
Purchase/Sale of Investments
31,313.00
28,818.00
7,044.00
34,874.00
21,000.00
Net Investing Cash Flow
34,175.00
43,279.00
2,853.00
28,544.00
19,830.00
Issuance/Reduction of Debt, Net
82,593.00
-
121,383.00
918.00
46,653.00
Net Financing Cash Flow
82,494.00
2,061.00
126,735.00
5,294.00
49,718.00
Net Change in Cash
50,034.00
68,354.00
97,755.00
96,432.00
32,478.00
Free Cash Flow
1,368.00
39,795.00
35,283.00
75,603.00
39,088.00
Deferred Taxes & Investment Tax Credit
-
-
9,635.00
-
696.00
Net Assets from Acquisitions
-
-
-
60,622.00
-
Change in Capital Stock
7,319.00
2,061.00
5,833.00
6,345.00
3,065.00
Exchange Rate Effect
221.00
802.00
741.00
375.00
848.00
Other Uses
-
1,000.00
-
-
-

About Endologix

View Profile
Address
2 Musick
Irvine California 92618
United States
Employees -
Website http://www.endologix.com
Updated 09/14/2018
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.